EQUITY RESEARCH MEMO

Neusoft Medical Systems

Generated 5/24/2026

Executive Summary

Conviction (model self-assessment)80/100

Neusoft Medical Systems is a leading Chinese medical technology company specializing in advanced imaging and diagnostic equipment, including CT, MRI, DSA, X-ray, PET/CT, and ultrasound systems. Founded in 2003 and headquartered in Shenyang, the company has grown to employ over 1,000 staff and serves healthcare institutions globally. Its integrated MDaaS (Medical Devices & Data as a Service) platform positions it as a comprehensive diagnostic solutions provider. With a strong domestic footprint and expanding international presence, Neusoft is well-placed to capitalize on the growing demand for affordable, high-quality medical imaging in emerging markets. The company's focus on digital health services and data-driven diagnostics aligns with industry trends toward value-based care and remote healthcare.

Upcoming Catalysts (preview)

  • Q3 2026Next-generation CT system launch (e.g., 256-slice or photon-counting CT)75% success
  • Q4 2026Expansion of MDaaS platform with AI-powered diagnostic tools and new partnerships70% success
  • Q2 2027Regulatory approval for a new MRI or PET/CT system in key international markets (e.g., FDA or CE mark)60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)